A carregar...

Characterization of CD22 Expression in Acute Lymphoblastic Leukemia

BACKGROUND: CD22 is a B-lineage differentiation antigen that has emerged as a leading therapeutic target in acute lymphoblastic leukemia (ALL). PROCEDURE: Properties of CD22 expression relevant to therapeutic targeting were characterized in primary samples obtained from children and young adults wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Shah, Nirali N., Stetler-Stevenson, Maryalice, Yuan, Constance M., Richards, Kelly, Delbrook, Cindy, Kreitman, Robert J., Pastan, Ira, Wayne, Alan S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405453/
https://ncbi.nlm.nih.gov/pubmed/25728039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!